A complete cross-over design evaluating canine acceptance of Carprieve® and Rimadyl® carprofen chewable tablets in healthy dogs.
Diana M A DewsburyKeith D DeDonderDarrell J RezacNatalia CernicchiaroPublished in: BMC veterinary research (2019)
Utilizing a 2 × 2 complete cross-over design, this study provides evidence that canine acceptability of a single-dose did not differ between Carprieve® and Rimadyl® chewable tablets.
Keyphrases